(RTTNews) - Biopharmaceutical company PTC Therapeutics, Inc. (PTCT) announced Monday the signing of an exclusive global license and collaboration agreement with Novartis Pharmaceuticals Corp., a ...
PTC Therapeutics, a rare-disease drug company best known for small-molecule therapies that alter gene expression, is partnering with Odylia Therapeutics to develop gene therapies for inherited eye ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results